|
|
Neuronally enriched transcripts according to a comparison of neuronal nuclei IP samples to total nuclei using isolation of nuclei from tagged specific cell types (INTACT) technology. |
DESEQ2, fold change > 2 and FDR < 0.01. |
WBPaper00062103:neuron_enriched
|
|
|
Transcripts that showed significantly increased expression glp-1(e2141); TU3401 animals comparing to in TU3401 animals. |
Fold change > 2, FDR < 0.01. |
WBPaper00065993:glp-1(e2141)_upregulated
|
|
|
Transcripts that showed significantly increased expression in ogt-1(ok1474) neuronal cells isolated by FACs comparing to in FACs isolated neuronal cells from wild type. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00066485:ogt-1(ok1474)_upregulated_neuron
|
|
|
Transcripts that showed significantly increased expression in 10-days post L4 adult hermaphrodite N2 grown at 20C, comparing to in 1-day post L4 adult hermaphrodite N2 animals grown at 20C. |
CuffDiff, fold change > 2. |
WBPaper00065096:Day10_vs_Day1_upregulated
|
|
|
Genes that were not enriched in either spermatogenic fem-3(q96gf) nor oogenic fog-2(q71) gonads, according to RNAseq analysis. |
To identify differentially expressed transcripts, authors used R/Bioconductor package DESeq. |
WBPaper00045521:Gender_Neutral
|
|
|
Transcripts that showed significantly increased expression in sftb-1(cer6) deletion homozygous comparing to to in N2 animals at L4 larva stage. |
DESeq2, fold change > 2 |
WBPaper00058725:sftb-1(cer6)_upregulated
|
|
|
Transcripts that showed significantly increased expression in mter-4(syb3662 syb3403) comparing to in N2. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00061995:mter-4(syb3662syb3403)_upregulated
|
|
|
Transcripts that showed significantly increased expression in unc-30(ok613) animals at L4 larva stage, comparing to N2 animals. |
Genes exhibiting at least two-fold change were considered differentially expressed. |
WBPaper00061439:unc-30(ok613)_upregulated
|
|
Temperature Shift: 25C vs 15C for 16 hours at L4 larva stage. |
Transcripts that showed significantly increased expression in AFD neurons comparing to in whole animals. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00065158:AFD_enriched
|
|
|
Transcripts that showed significantly decreased expression in ash-2(RNAi) comparing to in wild type animals injected with vector. |
Differential mRNA expression using DESeq2. mRNAs with a FDR < 0.05 and fold change > 2 considered differentially expressed. |
WBPaper00066232:ash-2(RNAi)_downregulated_WT
|
|
|
Transcripts that showed significantly decreased expression in lin-53(RNAi) embryos comparing to control animals. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00067044:lin-53(RNAi)_downregulated
|
|
|
Transcripts of noncoding genes that showed significantly increased expression in muscle. |
DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed. |
WBPaper00062325:muscle_enriched_noncoding-RNA
|
|
|
Transcripts that showed significantly increased expression (fold change > 2, adjusted p-value < 0.05) in EKM99[met-2(n4256) set-25(n5021)] injected with vector RNAi, comparing to in control animals (N2 injected with vector RNAi). |
Differential expression analysis was performed using DESeq2 v1.6.3 in R version 3.2.3. All analyses were performed with genes that had average expression level above 1 RPKM (fragments per kilobase per million, as calculated by Cufflinks). |
WBPaper00050193:met-2(n4256)set-25(n5021)_upregulated_L1
|
|
|
Transcripts that were enriched in muscle in day 12 animals, according to trans-splicing-based RNA tagging (SRT) and RNAseq. |
DESeq and Benjamini-Hochberg adjusted p-values were used. |
WBPaper00050053:muscle_enriched_Day12
|
